Since returning to the White House, President Trump has signed a series of executive orders reshaping federally funded ...
Axsome Therapeutics, Inc. , a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced the first patient has been dosed in the FORWARD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback